Current topics in medicinal chemistry最新文献

筛选
英文 中文
Natural-Derived Products and Nanomaterials for the Treatment of Cancer and Chronic Disorders (Part 1). 用于治疗癌症和慢性疾病的天然衍生产品和纳米材料(第1部分)。
IF 3.3 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-08-26 DOI: 10.2174/0115680266433261250821081843
Masoud Najafi
{"title":"Natural-Derived Products and Nanomaterials for the Treatment of Cancer and Chronic Disorders (Part 1).","authors":"Masoud Najafi","doi":"10.2174/0115680266433261250821081843","DOIUrl":"https://doi.org/10.2174/0115680266433261250821081843","url":null,"abstract":"","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Amarogentin, Natural Bitter Terpenoids: Research Update with Pharmacological Potential, Patent and Toxicity Aspects. Amarogentin,天然苦萜类化合物:药理潜力、专利和毒性研究进展。
IF 3.3 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-08-21 DOI: 10.2174/0115680266392073250808110715
Sonia Singh, Mahima Varshney, Himanshu Sharma
{"title":"Amarogentin, Natural Bitter Terpenoids: Research Update with Pharmacological Potential, Patent and Toxicity Aspects.","authors":"Sonia Singh, Mahima Varshney, Himanshu Sharma","doi":"10.2174/0115680266392073250808110715","DOIUrl":"https://doi.org/10.2174/0115680266392073250808110715","url":null,"abstract":"<p><p>Amarogentin is a secoiridoid glycoside that was initially isolated from the medicinal plant Swertia chirayita. It is well-known for its formidable bitter characteristics and the varied pharmacological actions it possesses. Especially in both conventional and modern medical practices, this molecule has garnered considerable attention due to its enormous therapeutic potential. Amarogentin possesses a wide range of biological actions, some of which include functions that are hepatoprotective, anti-inflammatory, anti-cancer, anti-diabetic, and antibacterial. The hepatoprotective function it possesses is achieved by enhancing antioxidant defense systems and reducing liver damage caused by toxins. It is believed that the ability of amarogentin to block proinflammatory mediators, such as TNF-α and IL-6, is responsible for its anti-inflammatory properties. The stimulation of apoptosis and the reduction of cancer cell proliferation in various tumor models are two additional ways in which it demonstrates promising anti-cancer potential. The antidiabetic activity of amarogentin is characterized by the modification of glucose metabolism as well as an improvement in insulin sensitivity. To enhance the therapeutic efficacy of amarogentin, further research is needed to investigate its bioavailability and stability in the human body. This is despite the fact that it possesses a wide range of pharmacological advantages. There are formulation options that could improve its pharmacokinetic profile. Some examples of these strategies are nanoparticle delivery systems and derivatization. In general, amarogentin exhibits a great deal of promise as a natural therapeutic agent for the treatment of liver diseases, cancer, and metabolic disorders. Accordingly, there is a need for further research into the mechanisms underlying its clinical applications and potential uses.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehension of the Function of Antioxidants in Targeting Different Signaling Pathways to Cure Oxidative Stress-Induced Hepatotoxicity. 抗氧化剂在不同信号通路治疗氧化应激引起的肝毒性中的作用。
IF 3.3 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-08-21 DOI: 10.2174/0115680266398364250811231140
Kartik Jadon, Swarupanjali Padhi
{"title":"Comprehension of the Function of Antioxidants in Targeting Different Signaling Pathways to Cure Oxidative Stress-Induced Hepatotoxicity.","authors":"Kartik Jadon, Swarupanjali Padhi","doi":"10.2174/0115680266398364250811231140","DOIUrl":"https://doi.org/10.2174/0115680266398364250811231140","url":null,"abstract":"<p><p>Oxidative stress plays a central role in the pathogenesis of liver diseases, including hepatotoxicity, by disrupting the balance between reactive oxygen species (ROS) and the hepatic antioxidant defense system. Excessive ROS production leads to inflammation, fibrosis, and cellular damage. Antioxidants-both endogenous and exogenous-can mitigate these effects by neutralizing ROS and restoring redox homeostasis. This review evaluates the mechanistic role of antioxidants in modulating key oxidative stress-related signaling pathways, such as nuclear factor erythroid 2-related factor 2 (Nrf2), mitogen-activated protein kinases (MAPKs), nuclear factorkappa B (NF-κB), phosphoinositide 3-kinase/Akt (PI3K/Akt), and Janus kinase/signal transducer and activator of transcription (JAK/STAT). Through the regulation of these pathways, antioxidants reduce apoptosis, suppress pro-inflammatory signaling, and enhance the expression of detoxifying enzymes. Natural compounds like flavonoids, polyphenols, and vitamins C and E have shown hepatoprotective effects, while synthetic antioxidants and their combinations with other therapeutic agents represent promising strategies for clinical application. This review underscores the therapeutic potential of antioxidants in combating oxidative stress-induced hepatotoxicity by offering a comprehensive overview of their mechanistic targets.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Druggable Targets in Zika Virus: A Systematic Review of Therapeutic Opportunities in Brazil. 寨卡病毒的可药物靶点:巴西治疗机会的系统回顾。
IF 3.3 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-08-21 DOI: 10.2174/0115680266388856250811094000
Washington Kleber Rodrigues Lima, Claudia Zeneida Gomes Parente Alves Lima, Víctor Kleber Gomes Parente Alves Lima, Willian Reis Rosário, Lidio Gonçalves Lima-Neto, Maria Tereza Dos Santos Correia, Glaucio Monteiro Ferreira, Luís Cláudio Nascimento da Silva
{"title":"Druggable Targets in Zika Virus: A Systematic Review of Therapeutic Opportunities in Brazil.","authors":"Washington Kleber Rodrigues Lima, Claudia Zeneida Gomes Parente Alves Lima, Víctor Kleber Gomes Parente Alves Lima, Willian Reis Rosário, Lidio Gonçalves Lima-Neto, Maria Tereza Dos Santos Correia, Glaucio Monteiro Ferreira, Luís Cláudio Nascimento da Silva","doi":"10.2174/0115680266388856250811094000","DOIUrl":"https://doi.org/10.2174/0115680266388856250811094000","url":null,"abstract":"<p><strong>Introduction: </strong>Zika virus (ZIKV), a flavivirus primarily transmitted by Aedes aegypti, became a major global health concern during the 2015-2016 outbreak, particularly in Brazil. Its association with congenital malformations and neurological disorders underscores the urgent need for effective therapeutic interventions. This review explores molecular targets for ZIKV treatment within the Brazilian context.</p><p><strong>Method: </strong>A systematic search was conducted using PubMed, ScienceDirect, and Scopus for studies published between 2004 and 2024. Inclusion criteria focused on studies identifying druggable molecular targets related to viral replication, immune evasion, or host-virus interactions. Key search terms included \"Zika virus,\" \"molecular targets,\" \"Brazil,\" \"antiviral,\" and \"drug discovery.\"</p><p><strong>Results: </strong>The review identified several critical viral proteins, NS1, NS3, NS5, and the envelope protein, as potential drug targets. Host cellular factors essential for viral survival were also highlighted. Technologies such as high-throughput screening, molecular docking, and structural genomics contributed significantly to the identification and validation of these targets.</p><p><strong>Discussion: </strong>Although promising targets have been identified, therapeutic development is hindered by the genetic variability of ZIKV and its antigenic similarity to other flaviviruses, notably the dengue virus. These challenges complicate the specificity and efficacy of drugs. Nevertheless, Brazil has made strides in research infrastructure and collaborations to tackle these obstacles.</p><p><strong>Conclusion: </strong>This review synthesizes current knowledge on ZIKV molecular targets and ongoing drug discovery efforts. The findings support the strategic development of antivirals and emphasize the necessity for sustained investment in research to mitigate future ZIKV outbreaks in Brazil and globally.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unlocking the Multifunctional Therapeutic Potential of Manassantin: A Lignan-Derived Scaffold. 解锁Manassantin的多功能治疗潜力:木脂素衍生支架。
IF 3.3 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-08-21 DOI: 10.2174/0115680266389940250812105153
Navin Kumar Tailor
{"title":"Unlocking the Multifunctional Therapeutic Potential of Manassantin: A Lignan-Derived Scaffold.","authors":"Navin Kumar Tailor","doi":"10.2174/0115680266389940250812105153","DOIUrl":"https://doi.org/10.2174/0115680266389940250812105153","url":null,"abstract":"<p><p>Manassantin, a dineolignan, is a natural compound that has gained significant attention due to its diverse pharmacological properties, including anti-inflammatory, anticancer, neuroprotective, and antimicrobial effects. Its unique polyphenolic scaffold offers a versatile platform for drug development, enabling targeted therapeutic applications. This review explores the molecular mechanisms underlying the bioactivity of manassantin with a focus on its role in modulating key cellular pathways, including NF-κB, MAPK, JAK/STAT, oxidative stress, apoptosis, and inflammatory signaling. Furthermore, it highlights recent advancements in structural modifications aimed at enhancing the pharmacokinetic and pharmacodynamic properties of this compound. By unlocking the full therapeutic potential of manassantin, this study paves the way for its future development as a multifunctional therapeutic agent.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Silico and In Vivo Hepatorenal Protective Effect of Chitosan-Loaded Chrysin Nanoparticles in Obese Rats. 壳聚糖纳米颗粒对肥胖大鼠的体内和体内肝肾保护作用。
IF 3.3 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-08-18 DOI: 10.2174/0115680266388484250807033921
Tahani Younis Omar, Saja Mohammad Al-Mosaidyyen, Esraa Nasser Mohammed, Nada Alaa Saied, Fatma Alzhraa Ayman, Juliana Kamal Khalil, Abdeljalil Mohamed Al Shawoush, Ayman Saber Mohamed
{"title":"In Silico and In Vivo Hepatorenal Protective Effect of Chitosan-Loaded Chrysin Nanoparticles in Obese Rats.","authors":"Tahani Younis Omar, Saja Mohammad Al-Mosaidyyen, Esraa Nasser Mohammed, Nada Alaa Saied, Fatma Alzhraa Ayman, Juliana Kamal Khalil, Abdeljalil Mohamed Al Shawoush, Ayman Saber Mohamed","doi":"10.2174/0115680266388484250807033921","DOIUrl":"https://doi.org/10.2174/0115680266388484250807033921","url":null,"abstract":"<p><strong>Introduction: </strong>Obesity, a widespread health condition marked by excessive body fat, markedly elevates the risk of chronic diseases and has emerged as a major global health issue. Chrysin, a flavonoid with promising health benefits, exhibits potent antioxidant and antiinflammatory properties. This study seeks to examine the impact of chitosan chrysin nanoparticles (Chrysin-CSNPS) on obesity induced by a high-fat diet (HFD) in male rats.</p><p><strong>Methods: </strong>Rats were fed a high-fat diet for 4 weeks to induce obesity, followed by a 4-week treatment period. Thirty rats were allocated into five groups (six rats per group): control (dist. water, orally), HFD control (dist. water, orally), HFD + chrysin (500 mg/kg, orally), HFD + chitosan-NP (60 mg/kg, orally), and HFD + Chrysin-CSNPS (60 mg/kg, orally).</p><p><strong>Results: </strong>In silico studies revealed that chrysin has a binding energy value of -8.8 kcal/mol to fat mass and obesity-associated (FTO) protein. Also, Chrysin is identified as an inhibitor of several cytochrome P450 enzymes, specifically CYP1A2, CYP2D6, and CYP3A4. Albumin, high-density lipoprotein cholesterol, glutathione, and nitric oxide levels rose, whereas glucose, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, creatinine, urea, total cholesterol, triglycerides, malondialdehyde, and nitric oxide levels fell upon Chrysin-CSNPS treatment. The histological examination revealed a significant enhancement in the structures of the liver and kidneys.</p><p><strong>Discussion: </strong>These findings suggest that chrysin could potentially inhibit FTO activity, thereby contributing to a reduction in obesity-related phenotypes. The compound that satisfied Lipinski's criteria was selected for toxicity prediction.</p><p><strong>Conclusion: </strong>Chrysin-CSNPS have hypolipidemic properties and an antioxidant role, reducing HFD consequences in the liver and kidney.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
UPLC-LCMS-Based Method Development, Validation, Forced Degradation, and Impurity Profiling of Nirogacestat Drug Substance. 基于uplc - lcms的硝格司他原料药的方法开发、验证、强制降解和杂质分析。
IF 3.3 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-08-15 DOI: 10.2174/0115680266407776250811045805
S R Thrinath, Manikandan Krishnan, K S Lakshmi, Sharad D Mankumare
{"title":"UPLC-LCMS-Based Method Development, Validation, Forced Degradation, and Impurity Profiling of Nirogacestat Drug Substance.","authors":"S R Thrinath, Manikandan Krishnan, K S Lakshmi, Sharad D Mankumare","doi":"10.2174/0115680266407776250811045805","DOIUrl":"https://doi.org/10.2174/0115680266407776250811045805","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;This study aims to establish a novel, straightforward, and reliable UPLCMS method for determining the stability and impurity profile of Nirogacestat under various stress conditions, in accordance with ICH guidelines. The stability of Nirogacestat was investigated under various stress conditions, including acid/base hydrolysis, oxidation (H2O2), photolysis, reduction, and thermal degradation. This research addresses the need for a validated, stability-indicating method that performs reliably across key analytical parameters, thereby contributing to pharmaceutical quality assurance.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;Stress testing was performed by exposing Nirogacestat to various degradation conditions, including acid (0.1 and 1N HCl), base (NaOH), oxidative (30% H₂O₂), thermal (105°C), photolytic, and reductive environments. The mobile phase consisted of acetonitrile and 0.1% triethylamine/formic acid, adjusted to pH 2.5 in a 30:70 (v/v) ratio. Chromatographic separation was achieved using an Acquity UPLC BEH Shield RP-18 column (50 × 1.0 mm, 1.7 μm), with a flow rate of 0.5 mL/min and detection at 251 nm. Linearity was evaluated over a concentration range of 0.25 to 1.5 μg/mL. Validation studies assessed parameters such as selectivity, linearity, accuracy, precision, robustness, and solution stability.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The method demonstrated excellent linearity (r² = 0.999), with peak area directly proportional to concentration within the studied range. All validation parameters were within acceptable limits. Forced degradation studies revealed distinct degradation products under each stress condition. Notably, alkaline degradation resulted in the least degradation, while acid, peroxide, photolytic, thermal, and reductive conditions produced a variety of degradation products. These were effectively separated from Nirogacestat using the developed method. The relative retention times for Nirogacestat and its impurities remained consistent, and mass spectrometry confirmed the identities of the degradation products.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Discussion: &lt;/strong&gt;The validated UPLC-MS method exhibited high sensitivity, selectivity, and robustness in detecting Nirogacestat and its impurities. It effectively distinguishes degradation products even within complex matrices and fully complies with ICH guidelines for analytical method validation. The degradation profile of Nirogacestat under various stress conditions provides critical insights into its stability behavior, which is essential for formulation development and regulatory compliance. The successful separation and identification of degradation products further underscore the method's applicability as a stability-indicating assay.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The developed UPLC-MS method is the first validated stability-indicating technique for Nirogacestat, offering comprehensive impurity profiling. It is precise, accurate, linear, and robust","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decoding Dementia Mechanisms: Identification of Key Oligodendrocyte-Associated Genes through Integrative Bioinformatics and Machine Learning. 解码痴呆机制:通过整合生物信息学和机器学习鉴定关键少突胶质细胞相关基因。
IF 3.3 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-08-13 DOI: 10.2174/0115680266384153250804110312
Yan Chen, Hao Wen, Xinyi Qiu, Chen Li, Yinhui Yao, Yazhen Shang
{"title":"Decoding Dementia Mechanisms: Identification of Key Oligodendrocyte-Associated Genes through Integrative Bioinformatics and Machine Learning.","authors":"Yan Chen, Hao Wen, Xinyi Qiu, Chen Li, Yinhui Yao, Yazhen Shang","doi":"10.2174/0115680266384153250804110312","DOIUrl":"https://doi.org/10.2174/0115680266384153250804110312","url":null,"abstract":"<p><strong>Introduction: </strong>This study aims to elucidate the mechanisms underlying Dementia using bioinformatics analysis and machine learning algorithms, to identify novel therapeutic targets for its clinical management.</p><p><strong>Methods: </strong>Gene expression datasets related to dementia were sourced from the GEO database. Differentially expressed genes (DEGs) were identified using R, and key module genes were determined through the Weighted Gene Co-expression Network Analysis (WGCNA) method. Oligodendrocyte (OL) related targets were retrieved from the GeneCards database. The intersecting genes from DEGs, WGCNA, and OL were analyzed using Gene Ontology and the Kyoto Encyclopedia of Genes and Genomes. Subsequently, three machine learning algorithms were employed to pinpoint core genes associated with OL in dementia. The CIBERSORT algorithm was used to evaluate the abundance of 22 immune cell types and their correlation with Dementia-related immune infiltration. Validation was carried out via quantitative reverse transcription polymerase chain reaction (RT-qPCR).</p><p><strong>Results: </strong>Through bioinformatics and machine learning techniques, six core OL genes associated with Dementia were identified, notably C1QA, CD163, and TGFB2, which showed elevated expression in Dementia. Immune cell infiltration analysis indicated that several immune cell types may contribute to Dementia's pathogenesis, and RT-qPCR results corroborated the bioinformatics findings.</p><p><strong>Discussion: </strong>The discovered genes may contribute to dementia pathogenesis through oligodendrocyte dysfunction and neuroimmune interactions. Notably, TGFB2 and complement-related genes (C1QA, CD163) suggest involvement in both myelination defects and neuroinflammation, highlighting their therapeutic potential.</p><p><strong>Conclusion: </strong>The six feature genes: TGFB2, C1QA, CD163, ACTG1, WIF1, and OPALIN are significantly linked to Dementia.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144854875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Structure-activity Relationship (SAR) Insight for the Most Effective Oral Antidiabetic Compounds-A Current Review. 最有效的口服降糖药的构效关系(SAR)研究综述
IF 3.3 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-08-13 DOI: 10.2174/0115680266379581250804035449
Fathiy Mutalabisin, Nader Ghaffari Khaligh
{"title":"A Structure-activity Relationship (SAR) Insight for the Most Effective Oral Antidiabetic Compounds-A Current Review.","authors":"Fathiy Mutalabisin, Nader Ghaffari Khaligh","doi":"10.2174/0115680266379581250804035449","DOIUrl":"https://doi.org/10.2174/0115680266379581250804035449","url":null,"abstract":"<p><p>Diabetes mellitus, a chronic metabolic disorder, poses a significant global health challenge, demanding continuous research into effective treatments. With projections of 629 million individuals affected by 2045 and escalating healthcare costs, the need for new anti-diabetic medications is urgent. Current therapies often present limitations, including undesirable side effects and insufficient long-term efficacy. This review explores the development of oral anti-diabetic drugs (OADs), focusing on the structure-activity relationship (SAR) employed to create both established and emerging classes of medications. We examine the six major OAD classes: biguanides, sulfonylureas, meglitinides, thiazolidinediones, DPP-4 inhibitors, and SGLT2 inhibitors. In addition, a new promising class of OAD, namely metal complexes, is discussed. This review highlights the crucial role of synthetic chemistry in advancing diabetes treatment and improving patient outcomes.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144854874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formononetin Mediates α7nAChR to Inhibit Macrophage Polarization and Ameliorate Atherosclerotic Plaque. 刺芒柄花素介导α7nAChR抑制巨噬细胞极化,改善动脉粥样硬化斑块。
IF 3.3 4区 医学
Current topics in medicinal chemistry Pub Date : 2025-08-12 DOI: 10.2174/0115680266382024250730194614
Li Du, Shirong Li, Qiansong He, Min Zhang, Wenxiu Wang
{"title":"Formononetin Mediates α7nAChR to Inhibit Macrophage Polarization and Ameliorate Atherosclerotic Plaque.","authors":"Li Du, Shirong Li, Qiansong He, Min Zhang, Wenxiu Wang","doi":"10.2174/0115680266382024250730194614","DOIUrl":"https://doi.org/10.2174/0115680266382024250730194614","url":null,"abstract":"<p><strong>Objective: </strong>To explore the molecular mechanism of α7 nicotinic acetylcholine receptor (α7nAChR) mediated by Formononetin (FMN) in inhibiting macrophage inflammatory polarization and stabilizing atherosclerotic plaque.</p><p><strong>Methods: </strong>SiRNA α7nAChR was transfected into THP-1-induced M0 cells and treated with FMN. Oil Red O staining was used to evaluate macrophage lipid deposition. RT-qPCR was used to detect α7nAChR, COX-2, IL-1β, IL-6, HO-1, and SHIP1 expression in M1 and M2 macrophages. Western blot was used to detect α7nAChR, iNOS, CD206, CD68, p-JAK2, and p-STAT3 protein expression in M1 and M2 macrophages.</p><p><strong>Results: </strong>Compared with the control group, FMN-mediated α7nAChR reduced lipid deposition in M1 and M2 macrophages. RT-qPCR results showed that FMN intervention significantly downregulated COX-2 and IL-1β expression in M1 (P < 0.05). α7nAChR expression significantly reduced COX-2, IL-6, and IL-1β expression in M2 (P < 0.05) and significantly increased HO-1 and SHIP1 expression (P < 0.05). FMN-mediated α7nAChR significantly decreased the expression of iNOS, CD68, p-JAK2, and p-STAT3 in M1 and M2 macrophages and significantly increased the expression of CD206 protein by Western blot (P < 0.05).</p><p><strong>Discussion: </strong>This study, for the first time, elucidated the mechanism of FMN regulating macrophage polarization through the α7nAChR/JAK2/STAT3 axis, providing new experimental evidence for the role of the cholinergic anti-inflammatory pathway in cardiovascular diseases. However, there are some limitations, such as the limited applicability of the THP-1 cell line, the need to strengthen the dose correlation study, the bioavailability and solubility limiting clinical translation, and the lack of human toxicological data.</p><p><strong>Conclusion: </strong>FMN effectively modulates macrophage polarization through inhibition of the JAK/STAT signaling pathway while promoting α7nAChR expression.</p>","PeriodicalId":11076,"journal":{"name":"Current topics in medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144871902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信